Synthesis and biological assessment of new pyrimidopyrimidines as inhibitors of breast cancer resistance protein (ABCG2).

Dakhlaoui I, Vahdati S, Maalej E, Chabchoub F, Wiese M, Marco-Contelles J, Ismaili L

Open source

DOI
10.1016/j.bioorg.2021.105326
Published
2021 Nov
Container
Bioorganic chemistry
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.bioorg.2021.105326,
  title = {Synthesis and biological assessment of new pyrimidopyrimidines as inhibitors of breast cancer resistance protein (ABCG2).},
  author = {Dakhlaoui I and Vahdati S and Maalej E and Chabchoub F and Wiese M and Marco-Contelles J and Ismaili L},
  year = {2021},
  journal = {Bioorganic chemistry},
  doi = {10.1016/j.bioorg.2021.105326},
  url = {https://doi.org/10.1016/j.bioorg.2021.105326}
}

RIS

TY  - JOUR
TI  - Synthesis and biological assessment of new pyrimidopyrimidines as inhibitors of breast cancer resistance protein (ABCG2).
AU  - Dakhlaoui I
AU  - Vahdati S
AU  - Maalej E
AU  - Chabchoub F
AU  - Wiese M
AU  - Marco-Contelles J
AU  - Ismaili L
PY  - 2021
JO  - Bioorganic chemistry
DO  - 10.1016/j.bioorg.2021.105326
UR  - https://doi.org/10.1016/j.bioorg.2021.105326
ER  - 

APA

I, D., S, V., E, M., F, C., M, W., J, M., & L, I. (2021). Synthesis and biological assessment of new pyrimidopyrimidines as inhibitors of breast cancer resistance protein (ABCG2).. Bioorganic chemistry. https://doi.org/10.1016/j.bioorg.2021.105326

Source records